Walter C Voegtli

Title: Walter C Voegtli: Innovator in Alkaline Phosphatase Research

Introduction

Walter C Voegtli is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of alkaline phosphatase polypeptides. With a total of 3 patents, Voegtli's work has the potential to impact the treatment of bone mineralization disorders.

Latest Patents

Voegtli's latest patents focus on alkaline phosphatase polypeptides and their methods of use. One of his key inventions includes polypeptides that feature soluble alkaline phosphatases, mutants, fragments, and fusion proteins. These innovations are aimed at treating bone mineralization disorders, such as hypophosphatasia (HPP), and alleviating associated symptoms. The polypeptides consist of a soluble alkaline phosphatase (sALP) or a fragment derived from a naturally occurring alkaline phosphatase (ALP). Another patent highlights pharmaceutical compositions that incorporate a soluble alkaline phosphatase for similar therapeutic applications.

Career Highlights

Walter C Voegtli is currently associated with Alexion Pharmaceuticals, Inc., where he continues to advance his research in the field. His work is instrumental in developing treatments that could significantly improve the quality of life for individuals suffering from bone mineralization disorders.

Collaborations

Voegtli has collaborated with notable colleagues, including Yuhong Wu and Jonathan Monteleone. Their combined expertise contributes to the innovative research and development efforts at Alexion Pharmaceuticals.

Conclusion

Walter C Voegtli's contributions to alkaline phosphatase research exemplify the impact of innovation in the medical field. His patents and ongoing work hold promise for advancing treatments for bone mineralization disorders.